Fulgent Genetics, Inc. (FLGT) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Fulgent Genetics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.898 and welcome to the Fulgen Genetics Q3 2025 conference call and webcast. 00:00:05.898 -- 00:00:09.063 At this time, all participants are in listening-only mode. 00:00:09.063 -- 00:00:12.747 A question-and-answer session will follow the formal presentation. 00:00:12.747 -- 00:00:16.652 You may be placed into question queue at any time by pressing star 1 on your telephone 00:00:16.652 -- 00:00:18.094 keypad. 00:00:18.094 -- 00:00:22.199 If anyone should require operator assistance, please press star 0. 00:00:22.199 -- 00:00:25.103 As a reminder, this conference is being recorded. 00:00:25.103 -- 00:00:29.225 It's now my pleasure to turn the call over to Lauren Sloan, Investor Relations. 00:00:29.225 -- 00:00:31.826 Please go ahead, Lauren. 00:00:31.948 -- 00:00:37.074 Good morning, and welcome to Fulgent's third quarter 2025 financial results conference 00:00:37.074 -- 00:00:42.261 call. On the call are Ming Hsieh, Chief Executive Officer, Paul 00:00:42.261 -- 00:00:48.188 Kim, Chief Financial Officer, and Brandon Purvis, Chief Commercial Officer. 00:00:48.188 -- 00:00:52.473 The company's press release discussing the financial results is available on the investor 00:00:52.473 -- 00:00:56.776 relations section of the company's website, ir.fulgentgenetics.com. 00:00:57.541 -- 00:01:01.947 A replay of this call will be available shortly after the call concludes on the investor 00:01:01.947 -- 00:01:05.252 relations section of the company's website. 00:01:05.252 -- 00:01:10.098 Management's prepared remarks and answers to your questions on today's call will contain 00:01:10.098 -- 00:01:15.005 forward-looking statements. These forward-looking statements represent management's estimates 00:01:15.005 -- 00:01:20.879 based on current views,...